Skip to main content

NLS Pharmaceutics Ltd. (NLSP)

NASDAQ: NLSP · IEX Real-Time Price · USD
2.65
+0.06 (2.32%)
After-hours:Sep 24, 2021 7:01 PM EDT
2.59
0.05 (1.97%)
At close: Sep 24, 4:00 PM
Market Cap30.47M
Revenue (ttm)n/a
Net Income (ttm)-2.86M
Shares Out12.07M
EPS (ttm)-0.41
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume56,233
Open2.53
Previous Close2.54
Day's Range2.49 - 2.63
52-Week Range2.06 - 7.35
Betan/a
Analystsn/a
Price Target10.00 (+286.1%)
Est. Earnings Daten/a

About NLSP

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of drug therapies to treat rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience, for the treatment of excessive daytime sleepiness and cataplexy; and Nolazol, for the treatment of ADHD. N...

IndustryBiotechnology
IPO DateJan 29, 2021
Stock ExchangeNASDAQ
Ticker SymbolNLSP
Full Company Profile

Financial Performance

Financial Statements

News

NLS Initiates Phase 2 Trial for Quilience in Narcolepsy and Announces First Patient Enrolled

STANS, SWITZERLAND / ACCESSWIRE / September 14, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery...

1 week ago - Accesswire

NLS Pharmaceutics to Participate in the 23rd Annual H.C. Wainwright Global Investment Conference

STANS, SWITZERLAND / ACCESSWIRE / September 8, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery ...

2 weeks ago - Accesswire

Buying Penny Stocks Right Now? 3 to Watch in 2021

Looking to buy penny stocks in 2021? Check these 3 out for your list The post Buying Penny Stocks Right Now?

Other symbols:SENSSONN
1 month ago - PennyStocks

NLS Pharmaceutics Announces Notice of Allowance for U.S. Patent Application Covering its Proprietary Mazindol Formula...

STANS, SWITZERLAND / ACCESSWIRE / August 19, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery an...

1 month ago - Accesswire

NLS Pharmaceutics to Participate in the Canaccord Genuity 41st Annual Growth Conference

STANS, SWITZERLAND / ACCESSWIRE / August 5, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and develo...

1 month ago - Accesswire

New Strong Sell Stocks for July 30th

AEVA, FTS, GOL, NLSP and PCH have been added to the Zacks Rank #5 (Strong Sell) List on July 30, 2021.

Other symbols:AEVAFTSGOLPCH
1 month ago - Zacks Investment Research

NLS Pharmaceutics Announces the Appointment of Eric Konofal, M.D., Ph.D. as Chief Scientific Officer

STANS, SWITZERLAND / ACCESSWIRE / July 19, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative...

2 months ago - Accesswire

Top Penny Stocks to Buy in 2021? 6 To Know About in July

Penny Stocks Are Heating Up Right Now; Here's 6 For Your July Watchlist The post Top Penny Stocks to Buy in 2021? 6 To Know About in July appeared first on Penny Stocks to Buy, Picks, News and Informati...

Other symbols:AUYCIDMDTSSIDEXLKCO
2 months ago - PennyStocks

NLS Pharmaceutics Announces FDA Acceptance of IND Application to Initiate Clinical Trials with Quilience(R) (mazindol...

Planned Phase 2a clinical trial anticipated to commence in August 2021 STANS, SWITZERLAND / ACCESSWIRE / July 15, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Sw...

2 months ago - Accesswire

NLS Pharmaceutics to Present at the Access to Giving Virtual Investor Conference on July 15th

STANS, SWITZERLAND / ACCESSWIRE / July 9, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and d...

2 months ago - Accesswire

NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021

STANS, Switzerland, June 2, 2021 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery an...

3 months ago - PRNewsWire

NLS Pharmaceutics to Present at The MicroCap Rodeo 2021 Summer Solstice: Best Ideas from the Buyside Conference on Ju...

STANS, Switzerland, May 28, 2021 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and develop...

3 months ago - PRNewsWire

NLS Pharmaceutics Announces New Study Data Confirming Mazindol's Unique Orexin Pathway Activation for Treating Narcol...

STANS, Switzerland, May 18, 2021 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and develop...

4 months ago - PRNewsWire